Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 26, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Developing a novel model system to target insulin-reactive CD8 T cells.

Gwen S Scott1, Sigal Fishman, Alon Margalit

  • 1Department of Cellular and Molecular Medicine, School of Medical Sciences, University of Bristol, Bristol, United Kingdom.

Annals of the New York Academy of Sciences
|January 6, 2009
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diurnal Variation of Islet Autoantibody Titers in Established Type 1 Diabetes Suggests Restricted-Time Sampling Improves Aab Measurement and Detection.

Research square·2026
Same author

Retroviral Transduction of Human CD4<sup>+</sup> T Cells with Membrane-Attached IL-10 Generates Type 1-Like Regulatory T Cells.

Human gene therapy·2026
Same author

IL17-deficient NOD mice are protected from autoimmune diabetes due to decreased antigen presentation and T cell activation.

Frontiers in immunology·2026
Same author

CXCR3 expression on antigen-experienced B cells is systemically dysregulated in type 1 diabetes.

Diabetologia·2025
Same author

<i>Pdgfrα</i> deficiency in islet β-cells up-regulates apoptosis of beta-cells and disturbs glucose metabolism in B6 mice.

Frontiers in endocrinology·2025
Same author

Is the NOD mouse a good model for type 1 diabetes?

Diabetologia·2025

Engineered InsCD3-zeta CD8 T cells effectively target and eliminate insulin-specific CD8 T cells. This novel immunotherapy approach shows promise for delaying or preventing autoimmune type 1 diabetes.

Area of Science:

  • Immunology
  • Endocrinology
  • Cellular Biology

Background:

  • CD8 T cells are implicated in the pathogenesis of autoimmune diabetes.
  • Targeting pathogenic immune cells is a potential strategy for disease prevention.

Purpose of the Study:

  • To develop and assess a novel cell-based therapy to eliminate insulin-specific CD8 T cells.
  • To evaluate the efficacy of engineered InsCD3-zeta CD8 T cells in targeting autoimmune responses.

Main Methods:

  • Development of engineered InsCD3-zeta CD8 T cells designed to recognize insulin-specific targets.
  • Co-culture of insulin-reactive target cells with activated or naïve InsCD3-zeta CD8 T cells.
  • Assessment of cytotoxicity to determine the killing capacity of InsCD3-zeta CD8 T cells.

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Related Experiment Videos

Last Updated: Jun 26, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Main Results:

  • Activated InsCD3-zeta CD8 T cells demonstrated significant cytotoxicity against insulin-reactive target CD8 T cells.
  • Naïve InsCD3-zeta CD8 T cells did not exhibit substantial killing activity.
  • The engineered cells specifically targeted and eliminated pathogenic T cells.

Conclusions:

  • Engineered InsCD3-zeta CD8 T cells represent a viable immunotherapeutic strategy.
  • This approach may offer a novel way to delay or prevent type 1 diabetes by removing key autoimmune effectors.